Developability of Biopharmaceuticals

-

By accounting for developability in candidate selection, drug developers have the potential to greatly minimize costly attrition and reduce development time significantly. However, this rapidly expanding area is not without its challenges, and key issues surrounding the early implementation of molecular assessments and rational engineering approaches need to be addressed.

Developability of Biopharmaceuticals has been designed to support drug developers in reducing the cost, risk and time of development. Our agenda focuses on the opportunities such as monitoring protein thermostability to ensure optimal conditions for bioprocess and exploring new high throughput screening methods to improve confidence in candidate selection.

Location:
Revere Hotel
USA


Organizer: Hanson Wade

4 Dec 2012

UPCOMING FEATURED EVENTS 1 Next 
ELRIG Drug Discovery 20142 Sep 2014 Read
Neuroscience 201415 Nov 2014 Read


ALL UPCOMING EVENTS
1 2 Next 
World Biosimilar Congress 201411 Nov 2014 Read
Advances in Cell Based Assays11 Nov 2014 Read
World Orphan Drug Congress Europe 201412 Nov 2014 Read
Medica 201412 Nov 2014 Read
HPAPI World Congress 201412 Nov 2014 Read
Neuroscience 201415 Nov 2014 Read
Translating Innovations in Diabetes Drug Development17 Nov 2014 Read
6th Annual Next Generation Sequencing Congress 201420 Nov 2014 Read
2nd Annual Single Cell Analysis Congress 201420 Nov 2014 Read
Pharmacovigilance, Drug Safety and Risk Management 201426 Nov 2014 Read
ASCB 20146 Dec 2014 Read